Status:
COMPLETED
Development and Validation of a Comorbidity Index in Crohn's Disease
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Crohn Disease
Eligibility:
All Genders
18-59 years
Brief Summary
Crohn's disease (CD) is a chronic inflammatory bowel disease (IBD). Like other chronic diseases, patients with CD may be affected by other diseases called comorbidities. The prevalence of comorbiditie...
Eligibility Criteria
Inclusion
- Patients between 18 and 59 years old
- Established diagnosis of CD with a minimum disease duration of 3 months
- Disease considered by the treating gastroenterologist to have been stable for at least 3 months
Exclusion
- Subject unable to comply with study procedures
- Surgery for CD 3 months prior to inclusion visit
Key Trial Info
Start Date :
April 4 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2025
Estimated Enrollment :
458 Patients enrolled
Trial Details
Trial ID
NCT05253378
Start Date
April 4 2022
End Date
March 31 2025
Last Update
May 6 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Laurent PEYRIN-BIROULET
Vandœuvre-lès-Nancy, France
2
San Raffaele Hospital
Milan, Italy